NIH-funded research R01 grant

Electronic tools to help doctors manage high blood pressure in kidney disease patients

Official title: Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease: A Multi-site Randomized Clinical Trial

Funded at Brigham and Women's Hospital · NIH-11416726 · Data updated 2026-11-12

A multi-site study tests an electronic decision-support tool within primary care to help treat high blood pressure in adults with chronic kidney disease.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2018
Project endJune 30, 2030
Funding year2026
Award (this year)$833,279
NIH project number5R01DK116898-07
Project IDNIH-11416726 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older with chronic kidney disease who visit primary care clinics and could benefit from BP management using evidence-based treatments.

Less likely to help

Patients without CKD or those not under primary care management for hypertension may not benefit from this tool.

What this research studies

This project builds on a previously tested computer tool that uses patient data from electronic health records to give primary care clinicians clear, evidence-based recommendations for managing hypertension in people with chronic kidney disease. It will implement and test the tool across three health systems to see if it consistently lowers systolic blood pressure and increases use of proven therapies. The team will also update the tool to address medication adherence and include new treatment recommendations, such as SGLT2 inhibitors. By making the tool user-friendly and aligned with clinic workflows, the study aims to improve how CKD and hypertension are managed in real-world primary care settings.

Why it matters

Potential benefit: If successful, patients with CKD could have better blood pressure control and reduced risk of kidney and cardiovascular complications through better-guided primary care management.

How similar studies have gone: Previous work showed the tool lowered systolic BP and increased appropriate RAASi therapy in a CKD population; this study tests generalizability.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Samal, Lipika — Brigham and Women's Hospital
  • Study coordinator: Samal, Lipika

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.